Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products Drug alert number:EL (23)A/24 Date issued: 13 July 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cipla (UK) Limited and Pharmathen S.A – Various Products Company name: Cipla (EU) Limited,
Read more
Drug alert number: EL (23)A/23 Date issued: 10 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Labetalol 200mg tablets (Tillomed Laboratories Ltd) Batch number Expiry date Pack size First distributed 221345 08/2025 56 (4×14) 15/05/2023 Active Pharmaceutical Ingredient: Labetalol hydrochloride Brief description of the problem
Read moreEmail addresses for the NHS Business Services Authority (NHSBSA) are changing. For pharmacy teams this means that some of the email addresses previously used to contact NHS Prescription Services will no longer work. There will be a small transition period where emails sent to the old address will be automatically forwarded. This ends on Tuesday
Read moreEmail addresses for the NHS Business Services Authority (NHSBSA) are changing. For pharmacy teams this means that some of the email addresses previously used to contact NHS Prescription Services will no longer work. There will be a small transition period where emails sent to the old address will be automatically forwarded. This ends on Tuesday
Read moreBy Stephen Thomas, Superintendent Pharmacist at Rowlands Pharmacy and Negotiating Team Member at Community Pharmacy England Last month the Government announced a £645m investment in community pharmacies to fund a Common Conditions Service and to support two existing pharmacy services. The detail is now being negotiated by us and officials at NHS England and the
Read moreCommunity Pharmacy England has published commentary and infographics to help pharmacy owners (our members) better understand the negotiating process. Our work to negotiate fair funding, as well as changes to NHS pharmacy services, with the Department of Health and Social Care (DHSC) and NHS England is a crucial part of our role. Understandably the sector
Read moreThe Health and Social Care Select Committee has published its report on ‘Digital transformation in the NHS’. Community Pharmacy England previously submitted a response to this inquiry on behalf of the Community Pharmacy IT Group. Many of the suggestions within our consultation response are incorporated into the final report. The committee acknowledges that the Covid-19
Read moreAs the NHS marks its 75th birthday, we at Community Pharmacy England want to use this opportunity to highlight and celebrate all of the highly skilled individuals that make community pharmacy such an exceptional and vital part of our society. Community pharmacy is an innovative sector having a huge positive impact on the health and
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Testosterone (Tostran®) 2% gel. MSN/2023/064 Tier 2 – medium impact Date of issue 4th July 2023 Testosterone (Tostran®) 2% gel is out of stock with no confirmed resupply date. Testavan® and Testogel® remain available and will be able to support increased
Read moreA new term of office for Local Pharmaceutical Committees (LPCs) in England began this weekend (Saturday 1st July). There are now 58 LPCs in England, and they will be known as Community Pharmacy <Local> to present a strengthened and unified identity to the local NHS, local government and other stakeholders, as the local voice of
Read more
